BLFS

BioLife Solutions Inc.

Price

$37.68

return (12m)

41.71%

p/e

31.76

p/bv

4.38

DIVIDEND YIELD

0.00%

BLFS price

BioLife Solutions

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BLFS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

6.14%

3 months

35.69%

1 year

41.71%

2 years

54.87%

5 years

-6.13%

10 years

1,993.33%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BLFS

Valuation

P/E

31.76

Sector 1.27

Industry 8.57

P/BV

4.38

Sector 1.88

Industry 3.63

P/Revenue (PSR)

17.26

Sector 1.56

Industry 3.09

EV/EBITDA

702.15

Sector -46.85

Industry -17.98

EV/EBIT

1,037.08

Sector -51.35

Industry -94.21

P/EBITDA

287.25

Sector -31.66

Industry 7.07

P/EBIT

617.68

Sector -43.19

Industry -32.11

P/Total Assets

4.11

Sector 0.87

Industry 1.32

P/Net Current Assets

17.10

Sector -26.04

Industry -3.44

P/Working Capital

15.19

Sector -4.00

Industry 7.65

EPS

1.19

Sector -0.70

Industry -0.23

BVPS

8.59

Sector 4.48

Industry 8.61

Efficiency

Gross Margin

63.61%

Sector 49.44%

Industry 55.16%

EBITDA Margin

8.80%

Sector -282.02%

Industry -13.47%

EBIT Margin

5.96%

Sector -164.03%

Industry -25.89%

Operating Margin

1.64%

Sector -19.60%

Industry -5.67%

Net Profit Margins

54.35%

Sector -23.82%

Industry -7.67%

Asset Turnover

0.06

Sector 0.13

Industry 0.13

Profitability

ROE

13.80%

Sector -23.80%

Industry -24.00%

ROA

12.96%

Sector -24.22%

Industry -5.96%

ROIC

2.03%

Sector -587.47%

Industry -21.90%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

9.69

Sector 1.90

Industry 2.56

Net Debt / EBITDA

-32.90

Sector -23.34

Industry 9.41

Net Debt / EBIT

-48.59

Sector -11.26

Industry -2.82

Net Debt / Equity

-0.20

Sector -0.63

Industry -0.19

Gross Debt / Equity

0.00

Sector -0.73

Industry 0.42

Equity/Assets

0.94

Sector 0.46

Industry 0.50

Liabilities/Assets

0.06

Sector 0.50

Industry 0.53

Growth

5Y Revenue CAGR

-2.19%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals BLFS

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF BioLife Solutions ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$37.68

Fair Value

$15.17

Upside

-59.75%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BLFS BioLife Solutions Inc.	$37.68	44.20%	0.00%	31.76	4.38	13.80%	54.35%
ABT Abbott Laboratories	$96.56	-25.26%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$86.94	-4.56%	3.30%	21.10	2.17	10.29%	13.93%
BSX Boston Scientific Corp.	$42.80	-55.35%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$77.58	-32.47%	0.00%	17.68	5.18	29.28%	22.69%
RMD ResMed Inc.	$220.18	-17.85%	1.12%	20.92	4.84	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$520.16	-16.12%	0.00%	36.04	25.47	70.67%	25.03%
COHR Coherent Inc.	$336.58	193.57%	0.00%	81.57	5.84	7.16%	11.31%
SYK Stryker Corp.	$275.16	-23.42%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$23.86	-10.29%	4.25%	17.60	1.72	9.80%	6.30%
INMD InMode Ltd.	$14.05	-8.08%	0.00%	10.69	1.32	12.32%	20.69%
BDX Becton Dickinson and Company	$176.01	-5.53%	2.39%	51.40	1.98	3.85%	6.29%
DXCM DexCom Inc.	$85.41	29.25%	0.00%	32.65	12.45	38.14%	20.12%
EW Edwards Lifesciences Corp.	$85.35	11.85%	0.00%	48.96	4.59	9.37%	15.43%
ALGN Align Technology Inc.	$145.01	13.72%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$26.32	-25.97%	2.96%	19.66	4.27	21.74%	9.20%
IRMD iRadimed Corporation	$85.25	22.44%	1.49%	47.27	10.71	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$87.75	-10.09%	1.10%	20.85	1.33	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BLFS - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT BioLife Solutions

BioLife Solutions Inc.

Average Investor10 user rating

4.0 (1 people)

United States

39 years

Founded: 1987

1992

Time since IPO - 34 years

199

Employees

BioLife Solutions Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.84 billion, with shareholders equity totaling $420.00 million.

The company employs approximately 199 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, BioLife Solutions Inc. reported $106.69 million in revenue, generating net income of $57.98 million.

Key financial metrics include a P/E ratio of 31.76, a price-to-book (P/B) ratio of 4.38, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BLFS.

Market cap

$1.84 billion

Net worth

$420.00 million

$420,003,000.00

Assets

$447.49 million

$447,494,000.00

Total Shares Outstanding

48.87 million

48,866,000

Average Daily Trading Volume

$917.72 Thousand

$917,721.82

Sector

Health

Industry

Medical Supplies and Equipment

BLFS

BLFS revenue and profits

Financial Results BLFS

DRAG THE FRAME TO SEE MORE DATA

BLFS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$86.67 15,38% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$267.68 --11,99% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$62.50 61,49% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$383.17 37,00% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$39.70 --18,93% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$255.81 38,68% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,139.27 36,51% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$428.58 0,25% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45